MS

Meva Singh

Active Director Director DIN 11205940
DIN 11205940 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value •••• Premium profile

About Meva Singh

Data last updated:

Meva Singh is a Director at Redinex Life Sciences Private Limited (since 2025). The company operates in Pharma. Redinex Life Sciences Private Limited reported revenue of ₹8.26 Cr (FY 2025).

DIN 11205940
Primary Designation Director
Industry Pharma
First Appointment 23 Jul 2025
Oldest Company Age 8 yrs
Largest company Redinex Life Sciences Private Limited · ₹8.26 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20252018₹8.26 Cr (FY 2025)Active

Board colleagues of Meva Singh

Directorship timeline

Open interactive timeline →
Redinex Life Sciences Private Limited
Premium access

Shareholding and investment profile for Meva Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meva Singh

Meva Singh currently holds 1 directorship: Redinex Life Sciences Private Limited (Director, since 23 Jul 2025, revenue ₹8.26 Cr (FY 2025)).

Meva Singh was first appointed on 23 Jul 2025 as Director at Redinex Life Sciences Private Limited.

The current boards of Meva Singh's companies include Gurdit Singh (Redinex Life Sciences Private Limited), Karan Deep Garg (Redinex Life Sciences Private Limited), Romi Bansal (Redinex Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available